Starks Associates Inc.
Records under this name other than the patents Starks Associates Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 7 of 7 · Back to Starks Associates Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,834,005 | Pyrrolobenzodiazepine Derivatives, Compositions Comprising the Same and Methods Related Thereto Lapsed on the fee record Ended Nov 16, 2018 · High confidence | Lapsed on the fee record | Ended Nov 16, 2018 | High confidence |
| US 7,511,032 | Pyrrolobenzodiazepine Derivatives, Compositions Comprising the Same and Methods Related Thereto Formerly held Lapsed on the fee record Ended Mar 31, 2017 · High confidence | Lapsed on the fee record | Ended Mar 31, 2017 | High confidence |
| US 4,215,070 | N-(Phosphonoacetyl)-L-aspartic acid compounds and methods for their preparation Term ended Term ended no later than Jul 29, 2000 · Low confidence | Term ended | Term ended no later than Jul 29, 2000 | Low confidence |
| US 4,267,126 | N-(Phosphonoacetyl)-L-aspartic acid compounds Term ended Term ended no later than May 12, 2001 · Low confidence | Term ended | Term ended no later than May 12, 2001 | Low confidence |
| US 4,348,522 | N-(phosphonacetyl)-L-aspartic acid salts with piperazine, cyclohexylamine and calcium Term ended Term ended no later than Sep 7, 2002 · Low confidence | Term ended | Term ended no later than Sep 7, 2002 | Low confidence |
| US 5,696,154 | Brefeldin A derivatives and their utility in the treatment of cancer Formerly held Term ended Term ended no later than Dec 9, 2017 · Low confidence | Term ended | Term ended no later than Dec 9, 2017 | Low confidence |
| US 5,824,674 | Brefeldin A derivatives and their utility in the treatment of cancer Term ended Term ended no later than Oct 20, 2018 · Low confidence | Term ended | Term ended no later than Oct 20, 2018 | Low confidence |